ILDR1 Gene Deafness Autosomal Recessive Type 42 NGS Genetic DNA Test
Comprehensive Genetic Testing for Hereditary Hearing Loss
The ILDR1 Gene Deafness Autosomal Recessive Type 42 NGS Genetic DNA Test represents a breakthrough in genetic diagnostics for hereditary hearing disorders. This advanced test specifically targets mutations in the ILDR1 (Immunoglobulin-like Domain Containing Receptor 1) gene, which plays a crucial role in the development and function of the inner ear. Understanding your genetic predisposition to hearing loss can significantly impact treatment decisions, family planning, and overall quality of life.
What Does This Test Measure?
Our comprehensive NGS-based genetic test analyzes the complete coding region of the ILDR1 gene to identify pathogenic variants associated with autosomal recessive nonsyndromic hearing loss type 42 (DFNB42). The test detects:
- Point mutations and single nucleotide variants
- Small insertions and deletions
- Copy number variations affecting the ILDR1 gene
- Novel genetic variants with potential clinical significance
Who Should Consider This Test?
This genetic test is recommended for individuals experiencing:
- Unexplained progressive hearing loss beginning in childhood or early adulthood
- Family history of genetic hearing impairment
- Consanguineous parents or family background
- Couples planning pregnancy with known family history of hearing disorders
- Children with delayed speech development due to hearing issues
- Individuals with normal hearing but carrying family genetic risk factors
Clinical Benefits of Genetic Testing
Understanding your genetic profile for hearing loss provides numerous advantages:
- Accurate Diagnosis: Confirms genetic cause of hearing impairment
- Treatment Guidance: Helps audiologists and ENT specialists develop targeted treatment plans
- Family Planning: Provides crucial information for genetic counseling and reproductive decisions
- Early Intervention: Enables proactive management and hearing preservation strategies
- Educational Planning: Assists in developing appropriate educational support for children
Understanding Your Test Results
Our comprehensive genetic report includes detailed interpretation of your results:
- Positive Result: Identifies pathogenic variants in the ILDR1 gene, confirming genetic diagnosis
- Negative Result: No disease-causing variants detected, though other genetic or environmental factors may contribute
- Variant of Uncertain Significance: Identifies genetic changes requiring further clinical correlation
- Carrier Status: Identifies individuals carrying one copy of mutated gene without symptoms
Test Pricing Information
| Price Type | Amount (USD) |
|---|---|
| Discount Price | $500 |
| Regular Price | $700 |
Nationwide Testing Availability
We have genetic testing facilities conveniently located across the United States, including major metropolitan areas such as New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, and many other cities. Our network of certified genetic counselors and medical professionals ensures you receive comprehensive support throughout the testing process.
Take Control of Your Hearing Health Today
Don’t let uncertainty about your hearing health affect your quality of life. Our ILDR1 Gene Deafness Autosomal Recessive Type 42 NGS Genetic DNA Test provides the clarity you need for informed medical decisions and family planning. With rapid turnaround times of 3-4 weeks and simple sample collection (blood, extracted DNA, or one drop of blood on FTA card), getting answers has never been easier.
Call or WhatsApp us today at +1(267) 388-9828 to schedule your genetic test consultation and take the first step toward understanding your genetic hearing health.
